Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,086 | 353 | 98.9% |
| Education | $69.61 | 5 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $920.29 | 68 | $0 (2024) |
| Amgen Inc. | $853.10 | 45 | $0 (2024) |
| GlaxoSmithKline, LLC. | $741.12 | 44 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $666.71 | 36 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $463.21 | 29 | $0 (2023) |
| Merck Sharp & Dohme LLC | $421.16 | 28 | $0 (2023) |
| PFIZER INC. | $346.91 | 26 | $0 (2023) |
| Lilly USA, LLC | $326.43 | 16 | $0 (2024) |
| Mylan Specialty L.P. | $184.81 | 8 | $0 (2024) |
| Mannkind Corporation | $176.86 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $909.67 | 46 | AstraZeneca Pharmaceuticals LP ($325.78) |
| 2023 | $1,274 | 75 | Merck Sharp & Dohme LLC ($180.11) |
| 2022 | $1,200 | 70 | Mannkind Corporation ($176.86) |
| 2021 | $742.92 | 49 | SANOFI-AVENTIS U.S. LLC ($127.35) |
| 2020 | $683.80 | 43 | Novo Nordisk Inc ($258.51) |
| 2019 | $1,181 | 64 | Amgen Inc. ($327.04) |
| 2018 | $164.55 | 11 | Amgen Inc. ($77.09) |
All Payment Transactions
358 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $34.02 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Bone Health | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Respiratory | ||||||
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Obesity | ||||||
| 09/17/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Neurology | ||||||
| 09/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Oncology | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: RESPIRATORY | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/22/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: RESPIRATORY | ||||||
| 08/21/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Endocrinology | ||||||
| 08/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Cardio-renal | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Inflammation | ||||||
| 07/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: RESPIRATORY | ||||||
| 07/01/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: UROLOGY | ||||||
| 06/25/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,013 | 1,893 | $244,873 | $88,434 |
| 2022 | 24 | 932 | 1,719 | $224,793 | $71,581 |
| 2021 | 4 | 376 | 907 | $262,170 | $52,582 |
| 2020 | 5 | 528 | 1,146 | $310,827 | $55,009 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 182 | 535 | $131,075 | $42,595 | 32.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 91 | 91 | $20,020 | $8,929 | 44.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 24 | 26 | $8,450 | $7,341 | 86.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 86 | $15,050 | $5,059 | 33.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 53 | 54 | $4,055 | $3,871 | 95.5% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 24 | 44 | $8,800 | $3,076 | 35.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 13 | $5,135 | $2,580 | 50.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 17 | $4,760 | $2,490 | 52.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 153 | 279 | $5,650 | $2,344 | 41.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 55 | 56 | $1,960 | $1,558 | 79.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 28 | 34 | $7,298 | $1,507 | 20.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 36 | 39 | $6,045 | $1,469 | 24.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $5,985 | $1,455 | 24.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 67 | 151 | $6,418 | $1,382 | 21.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 16 | 33 | $3,630 | $938.19 | 25.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 62 | 96 | $2,544 | $783.65 | 30.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 22 | 22 | $990.00 | $612.26 | 61.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 38 | 38 | $2,888 | $346.09 | 12.0% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 25 | 168 | $2,856 | $65.48 | 2.3% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 23 | 92 | $1,265 | $32.11 | 2.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 184 | 540 | $140,110 | $41,461 | 29.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 18 | 18 | $5,850 | $5,005 | 85.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 85 | $15,304 | $4,621 | 30.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 42 | 42 | $3,150 | $2,879 | 91.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 32 | 47 | $8,722 | $2,169 | 24.9% |
About Dr. Kevin O'sullivan, M.D
Dr. Kevin O'sullivan, M.D is a Family Medicine healthcare provider based in Texarkana, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2015. The National Provider Identifier (NPI) number assigned to this provider is 1922492859.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin O'sullivan, M.D has received a total of $6,155 in payments from pharmaceutical and medical device companies, with $909.67 received in 2024. These payments were reported across 358 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($6,086).
As a Medicare-enrolled provider, O'sullivan has provided services to 2,849 Medicare beneficiaries, totaling 5,665 services with total Medicare billing of $267,607. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Texarkana, AR
- Active Since 03/28/2015
- Last Updated 06/20/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1922492859
Products in Payments
- Ozempic (Drug) $557.42
- TRELEGY ELLIPTA (Drug) $521.33
- EVENITY (Biological) $334.61
- FARXIGA (Drug) $329.66
- BELSOMRA (Drug) $329.16
- ELIQUIS (Drug) $224.40
- Repatha (Biological) $218.09
- BREZTRI (Drug) $214.04
- Aimovig (Biological) $199.73
- SOLIQUA 100/33 (Biological) $194.93
- AFREZZA (Drug) $176.86
- Rybelsus (Drug) $156.48
- YUPELRI (Drug) $145.64
- VRAYLAR (Drug) $127.51
- XARELTO (Drug) $116.80
- TOUJEO (Biological) $105.44
- TRULICITY (Drug) $104.47
- Tresiba (Drug) $101.63
- ANORO (Drug) $88.87
- PREMARIN (Drug) $87.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Texarkana
Gregory Richter, Md, MD
Family Medicine — Payments: $11,589
Dr. Claudia Jordan, M.d, M.D
Family Medicine — Payments: $9,473
Paul Gardial, M.d, M.D
Family Medicine — Payments: $8,603
Dr. Blane Graves, Md, MD
Family Medicine — Payments: $8,027
Herman Kile, Md, MD
Family Medicine — Payments: $7,630
Mr. James Sarrett, Md, MD
Family Medicine — Payments: $7,382